oxazolidin-2-one has been researched along with ta 0910 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ijiro, T; Inada, H; Ishibashi, H; Kiguchi, S; Kobayashi, M; Maruyama, K; Nabekura, J; Nakamura, K; Ogata, M | 1 |
| Abe, Y; Ijiro, T; Kiguchi, S; Yaguchi, A; Yokoyama, A | 1 |
2 other study(ies) available for oxazolidin-2-one and ta 0910
| Article | Year |
|---|---|
Effect of rovatirelin, a novel thyrotropin-releasing hormone analog, on the central noradrenergic system.
Topics: Action Potentials; Administration, Oral; Adrenergic Neurons; Animals; Dose-Response Relationship, Drug; Ligands; Locus Coeruleus; Male; Microdialysis; Motor Activity; Norepinephrine; Oxazolidinones; Prefrontal Cortex; Protein Binding; Proto-Oncogene Proteins c-fos; Pyrrolidines; Radioligand Assay; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Thyrotropin-Releasing Hormone; Thyrotropin-Releasing Hormone; Time Factors | 2015 |
Ameliorating effect of rovatirelin on the ataxia in rolling mouse Nagoya.
Topics: Animals; Ataxia; Behavior, Animal; Brain; Brain-Derived Neurotrophic Factor; Disease Models, Animal; Female; Glucose; Male; Mice; Oxazolidinones; Pyrrolidines; Spinocerebellar Degenerations; Thyrotropin-Releasing Hormone | 2020 |